Results from the OlympiA Trial on Olaparib for High-Risk Breast Cancer Patients

Results from the OlympiA Trial on Olaparib for High-Risk Breast Cancer Patients Today we were a part of a pivotal moment in breast cancer research at SABCS 2024. The long-term follow-up results from the OlympiA trial, a phase 3, multicenter study, have been shared, bringing new hope for patients with high-risk HER2-negative primary breast cancer who carry […]

Immediate vs. Deferred Breast Surgery in Women Aged 70+

We’re reporting live from the San Antonio Breast Cancer Symposium (SABCS) 2024, where new research is shaping the future of breast cancer care. One of the highlights so far is a study addressing a critical question for women aged 70 and older with operable breast cancer: Is immediate surgery necessary, or can it safely be […]

Mohawk College Students Advancing Breast Cancer Research

Mohawk College Students Advancing Breast Cancer Research Hamilton’s next generation of advertisers are driving groundbreaking research to improve outcomes for breast cancer patients. This holiday season, Breast Cancer Canada is partnering with advertising students from Mohawk College, The Agency, to launch Progress Is Our Gift, a dynamic campaign designed to encourage Canadians to give the […]